Macrophage iron dyshomeostasis promotes aging-related renal fibrosis

Lingzhi Wu1, Hongchun Lin1, Shaomin Li1

  • 1Nephrology Division, Department of Medicine, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Aging Cell
|July 17, 2024
PubMed

Insights

Macrophages drive kidney aging and fibrosis through ferroptosis. Targeting iron metabolism in macrophages with compounds like Rutin may offer therapeutic benefits for age-related kidney disease.

Area of Science:

  • Gerontology
  • Nephrology
  • Immunology

Background:

  • Renal aging is characterized by senescent cells and chronic inflammation, leading to fibrosis and dysfunction.
  • Macrophages are key inflammatory regulators implicated in age-related kidney damage.

Purpose of the Study:

  • To investigate the role of macrophages in renal aging.
  • To elucidate the mechanisms of macrophage-driven inflammation and fibrosis.
  • To identify potential therapeutic targets for age-related kidney disease.

Main Methods:

  • Single-cell RNA sequencing of mouse kidneys across aging spectrum.
  • CellChat and SCENIC analyses for cell communication and transcription factor inference.
  • In vitro ferroptosis suppression and virtual screening of anti-aging compounds.

Main Results:

  • Increased macrophage infiltration in aging kidneys, exhibiting senescence and ferroptosis.
  • Macrophage-to-tubular cell communication is enhanced with aging.
  • Stat1 and Pcbp1 are identified as key regulators of macrophage ferroptosis.
  • Rutin suppresses macrophage senescence and ferroptosis by targeting Pcbp1.

Conclusions:

  • Macrophage ferroptosis is a critical driver of renal aging and fibrosis.
  • Pcbp1 is a potential therapeutic target for intervention.
  • Rutin shows promise as a therapeutic agent for mitigating age-related kidney inflammation and fibrosis.